The epidemiological changes of HCV and HBV infections in the era of new antiviral therapies and the anti-HBV vaccine

摘要: The World Health Organization (WHO) resolution adopted in 2010 recognized viral hepatitis as a global health problem. In April 2014, for the first time, WHO produced guidelines screening, care and treatment of persons with C infections. May follow-up urged Member States to develop implement national strategy prevention, diagnosis based on local epidemiological context. Although blood donor which began early 1990s, has reduced spread virus population, estimates that 150 million people are chronically infected (HCV) at an increased risk developing liver cirrhosis hepatocellular carcinoma. addition, 3-4 each year. HCV is currently evolving rapidly, several drugs various stages development. With regard B (HBV), March 2015, published chronic infection, were designed complement recent HCV. introduction effective vaccine against prevalence economic impact industrialized countries, more than 2 billion HBV-infected 350 carriers.